Extracellular bromide enhances GABAA receptor function in the immature, but not the adolescent rat pilocarpine
Heiner Kolp1, Jana K Hackert1, Marco Heerdegen1
1Oscar Langendorff Institute of Physiology, University of Rostock, Rostock, Germany.
Insights
Immature rats treated with pilocarpine showed enhanced GABAergic inhibition with bromide, unlike adolescent rats. This suggests immature models are crucial for developing infant epilepsy therapies.
Area of Science:
- Neuroscience
- Epilepsy Research
- Pharmacology
Background:
- Status epilepticus (SE) is a neurological emergency characterized by prolonged seizures.
- Pilocarpine-induced SE is a standard model for studying epilepsy in rodents.
- The effects of bromide on GABAergic neurotransmission may differ between immature and adult brains.
Purpose of the Study:
- To investigate the impact of extracellular bromide on GABAergic neurotransmission in a novel immature rat pilocarpine model.
- To compare these effects with those observed in a standard adolescent rat pilocarpine model.
- To evaluate the potential of immature models for epilepsy research.
Main Methods:
- An immature rat model was established using repetitive pilocarpine administration (340 mg/kg on postnatal days 9, 11, 15).
- Electrophysiological recordings of Schaffer collateral CA1-synapse and CA1 pyramidal neurons were conducted in 30-70 day-old animals.
- Extracellular bromide (20 mM) was introduced by replacing NaCl with NaBr in the bath solution, and findings were compared to an adolescent model (single pilocarpine dose on postnatal day 30).
Main Results:
- Extracellular bromide significantly enhanced the GABAA-receptor component of inhibitory postsynaptic potentials in the immature model.
- Bromide application led to hyperpolarization of the GABAA-receptor reversal potential and reduced intrinsic neuronal excitability in immature rats.
- Long-term potentiation, induced by high-frequency stimulation, remained unaffected by bromide in both immature and adolescent models.
Conclusions:
- The immature rat model demonstrated persistent bromide-enhanced GABAA-receptor function and reduced excitability, effects not observed in the adolescent model.
- These findings highlight the distinct neurophysiological characteristics of immature brains in response to pilocarpine and bromide.
- Immature animal models are essential for exploring novel therapeutic strategies targeting infantile epilepsies.
Objective:
To study the effects of extracellular bromide in a novel immature rat pilocarpine model compared to the standard adolescent rat model.
Methods:
We employed an immature rat model of repetitive pilocarpine-induced status epilepticus (340 mg/kg on postnatal days 9, 11 and 15). The electrophysiological characterization of the Schaffer collateral CA1-synapse and of CA1 pyramidal neurons was performed in 30-70 day-old animals. To explore the effects of bromide, 20 mM NaCl in the bath solution was replaced by 20 mM NaBr. We compared our findings in the immature model with data from the standard adolescent model of a single pilocarpine-induced status epilepticus (340 mg/kg on postnatal day 30) obtained from 40-90 day-old animals.
Results:
In the immature, but not in the adolescent model, extracellular bromide (20 mM) enhanced the GABAA-receptor component of the inhibitory postsynaptic potential, hyperpolarized the GABAA-receptor reversal potential and reduced intrinsic excitability. However, bromide left high-frequency stimulation-induced long-term potentiation unaltered - in both the immature and the adolescent model.
Significance:
The immature model, but not the commonly used adolescent pilocarpine model, showed a persistent bromide-enhanced GABAA-receptor function leading to reduced intrinsic excitability. Hence, we suggest that immature animal models are needed to explore novel therapeutic strategies for epilepsies acquired during infancy.
Related Concept Videos
Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Halogenation of Alkenes
Consider the bromination of cyclopentene. Molecular bromine is polarized in the proximity of the π electrons of cyclopentene. An electrophilic bromine atom adds across the double bond, forming a cyclic bromonium ion intermediate.
Radical Substitution: Allylic Bromination
G-Protein Gated Ion Channels
Sensory...


